Antipsychotics / השמנת יתר חולנית

Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

FIELD OF INVENTION The present invention relates to compounds that modulate 5-HT(2) receptors. More particularly, the present invention relates to highly selective 5-HT(2C) agonists that also may exhibit antagonist activity at the 5-HT(2B) receptor. The compounds are used methods of treating

Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

FIELD OF INVENTION The present invention relates to compounds that modulate 5-HT(2) receptors. More particularly, the present invention relates to highly selective 5-HT(2C) agonists that also may exhibit antagonist activity at the 5-HT(2B) receptor. The compounds are used methods of treating

5-HT.sub.2C receptor agonists and compositions and methods of use

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Obesity is a life-threatening disorder in which there is an increased risk of morbidity and mortality arising from concomitant diseases such as type II diabetes, hypertension, stroke, cancer, and gallbladder disease. Obesity is now a major healthcare issue in the Western World and increasingly in

5-HT.sub.2C receptor agonists and compositions and methods of use

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Obesity is a life-threatening disorder in which there is an increased risk of morbidity and mortality arising from concomitant diseases such as type II diabetes, hypertension, stroke, cancer, and gallbladder disease. Obesity is now a major healthcare issue in the Western World and increasingly in

5-HT2C receptor agonists and compositions and methods of use

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

Obesity is a life-threatening disorder in which there is an increased risk of morbidity and mortality arising from concomitant diseases such as type II diabetes, hypertension, stroke, cancer, and gallbladder disease. Obesity is now a major healthcare issue in the Western World and increasingly in

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted TRP derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amino acid analogs as CCK antagonists

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting as agonists at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh, and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes, and Pittaway, Neuropharmacology 26:289-300, 1987), and as

N-substituted cycloalkyl and polycycloalkyl polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Cholecystokinin antagonists, their preparation and therapeutic use

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh, and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes, and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Cholecystokinin antagonists, their preparation and therapeutic use

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE INVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh, and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes, and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

Amico acid derivatives cyclized at the C-terminal

רק משתמשים רשומים יכולים לתרגם מאמרים

התחבר הרשם

BACKGROUND OF THE lNVENTION Agents acting at central cholecystokinin (CCK) receptors may induce satiety (Schick, Yaksh and Go, Regulatory Peptides 14:277-291, 1986). They are also expected to act as analgesics (Hill, Hughes and Pittaway, Neuropharmacology 26:289-300, 1987), and as anticonvulsants

antipsychotics/השמנת יתר חולנית

Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor

Highly selective 5-HT(2C) receptor agonists that show anti-psychotic effects with antagonist activity at the 5-HT(2B) receptor

5-HT.sub.2C receptor agonists and compositions and methods of use

5-HT.sub.2C receptor agonists and compositions and methods of use

5-HT2C receptor agonists and compositions and methods of use

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted TRP derivatives

Amino acid analogs as CCK antagonists

N-substituted cycloalkyl and polycycloalkyl polyhydro-.beta.-carboline-phenylalanine- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl .alpha.-substituted Trp-Phe- and phenethylamine derivatives

N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

Cholecystokinin antagonists, their preparation and therapeutic use

Cholecystokinin antagonists, their preparation and therapeutic use

Amico acid derivatives cyclized at the C-terminal

המאגר השלם ביותר של צמחי מרפא המגובה על ידי המדע